Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Payments • Healthcare (& Wellness) • Life Science • Mobile • Oncology • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Series A |
Investing | United States • Israel |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Broadview Ventures is a venture capital firm based in Boston, Massachusetts, that was founded in 2008 with a focus on impact investing, particularly in companies developing technology for the diagnosis and treatment of cardiovascular and neurovascular diseases. Their mission is to accelerate the development of promising technology in these areas through targeted investments, aiming to get treatments to patients and create a diversified portfolio across various technologies. Broadview Ventures specializes in seed and Series A investments with an expertise in equity investments. Their typical investment range is from $100,000 to $5,000,000, with a sweet spot of around $1,500,000 for the deals they pursue. The firm invests in several industries including BioTech, HealthTech, Medical Devices, Payments, Healthcare, Life Science, Mobile, Oncology, Consumer, and Pharmaceutical. Their portfolio includes a range of innovative companies such as Cardiosense, Comanche Biopharma, CorFlow, IsomAb, Nyra Medical, Puzzle Medical Devices, RapidPulse, and others. Each portfolio company has its unique approach and focus area, offering solutions like physiological waveform AI platforms, siRNA therapies for preeclampsia, technologies to address microvascular obstruction, specific antibodies for VEGF isoforms, devices for treating mitral regurgitation, and various others targeting different cardiovascular and neurovascular conditions. Broadview Ventures supports these companies in achieving their goals by providing funding and strategic guidance to fuel their growth and development in the healthcare sector.